Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy
The aim of this study is to sample and analyze volatile organic compounds (VOCs) from lung cancer patients and individuals without lung cancer ("healthy" controls). The breath sample analysis will help investigators describe and identify profiles of VOCs found in the breath of patients with lung cancer when compared to normal breath profiles using infrared spectroscopy. This work will help validate early proof of concept results conducted with prototype technology and later stage NSCLC breath samples, and inform future breath testing analysis.
Checked against the public recordLast updated Nov 18, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Breathe BioMedical Inc
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria LC Group: * ≥ 18 years; * Able to give informed consent; * Eligible for lung cancer screening or lung cancer follow-up testing (biopsy, surgery); * Clinical evidence of lung cancer (metastatic or primary), inclusive of those receiving non-curative treatment, has not yet been treated or is not currently on treatment; * No history of or any other active cancer; * Able to provide a breath sample; Control Group: * ≥ 18 years; * Able to give informed consent; * Eligible for lung cancer screening or lung cancer follow-up testing (biopsy, surgery); * No history of lung cancer or any other active cancer and is eligible for lung cancer screening; * Able to provide a breath sample; Exclusion Criteria * Has received or is currently receiving curative treatment and may no longer have lung cancer; * Cannot give informed consent;
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mia MartinezOrange, California
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 18, 2023. Always confirm current availability with the study team.